Abstract
Backround: Over the last decade a synchronous resection of liver metastases and cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (CRS+HIPEC) have emerged. It is still more widely accepted in cases of small peripheral hepatic lesions. We report short- and long-term outcome of patients undergoing CRS+HIPEC combined with liver resections.
Full Text
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call